Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 236,566,338 papers from all fields of science
Search
Sign In
Create Free Account
orlistat
Known as:
(-)-Tetrahydrolipstatin
, Orlipastat
, tetrahydrolipastatin
Expand
A reversible active-site inhibitor of gastrointestinal lipases. Orlistat forms a covalent bond with the active serine site in gastric and pancreatic…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
Narrower (3)
Alli
Xenical
orlistat 120 MG Oral Capsule [Xenical]
Broader (3)
Anti-Obesity Agents
Enzyme Inhibitors
Lactones
Cholestasis
Drug Allergy
Lipase Inhibitors [MoA]
Malabsorption Syndrome
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
ПРОФИЛАКТИЧЕСКОЕ ВЛИЯНИЕ ОРЛИСТАТА НА КАРДИОВАСКУЛЯРНЫЕ РИСКИ У МОЛОДЫХ ПАЦИЕНТОВ С ОЖИРЕНИЕМ
Елена Вячеславовна Корнеева
2015
Corpus ID: 74765528
Aim. To study the dynamics of cardiovascular risk factors in younger patients with obesity at the background of orlistat…
Expand
2015
2015
Current concepts on Eating Disorders , Etiology and Treatment
M. Mustafa
,
M. Hashmi
,
Em. Illzam
,
A. Sharifa
,
Nang Mk
,
T. Win
2015
Corpus ID: 36054567
Anorexia nervosa (AN), bulimia nervosa (BN) and obesity are eating disorders (ED) are considered to be mental illness, while…
Expand
2014
2014
Effect of Exercise and Orlistat Therapy in Rat Model of Obesity Induced with High Fat Diet
S. Eleawa
,
Hussein F Sakr
2014
Corpus ID: 25128395
Background: The prevalence of obesity is increasing rapidly and, has largely been attributed to increased dietary intake of high…
Expand
2012
2012
Angiotensin II Induces Vascular Endocannabinoid Release , Which Attenuates Its Vasoconstrictor Effect via CB 1 Cannabinoid Receptors *
M. Szekeres
,
G. Nádasy
,
+5 authors
L. Hunyady
2012
Corpus ID: 23012312
Mária Szekeres, György L. Nádasy, Gábor Turu, Eszter Soltész-Katona, Zsuzsanna E. Tóth, András Balla , Kevin J. Catt**, and Lászl…
Expand
2010
2010
Opyt primeneniya preparata Orsoten (orlistat)u bol'nykh ozhireniem
A. Mel'nichenkoG
,
A. KomshilovaK
,
A. BerkovskayaM
2010
Corpus ID: 72130828
At present, the epidemic of overweight and obesity is one of the most pressing public health problems worldwide. Pharmacotherapy…
Expand
2000
2000
Adipositastherapie in der gynäkologischen Praxis
B. Kleine-Gunk
2000
Corpus ID: 55820465
Review
1999
Review
1999
Orlistat (Xenical).
A. MacConnachie
Intensive & Critical Care Nursing
1999
Corpus ID: 21682828
The introduction of orlistat (Roche, UK) at the end of last year received considerable media coverage and was heralded in some…
Expand
1999
1999
[How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine]
R. Wo
1999
Corpus ID: 68484007
Sibutramine and Orlistat are suitable "supporting drugs" for use in patients trying to lose weight. Orlistat reduces the…
Expand
1993
1993
Comparison of Galenic Formulations of Orlistat (Tetrahydrolipstatin)
D. Hartmann
,
C. Güzelhan
,
H. Crijns
,
P. Peeters
,
P. Persson
,
J. Jonkman
1993
Corpus ID: 92446527
SummaryOrlistat (tetrahydrolipstatin) reduces absorption of dietary fat by inhibiting lipases in the gastrointestinal tract…
Expand
1988
1988
Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin
Bengt Borgstriim
1988
Corpus ID: 53481364
Tetrahydrolipstatin is a specific lipase inhibitor derived from lipstatin, a lipid produced by Streptomyces toxytricini In…
Expand